HIGHLIGHTS
- who: David I. Dolling from the WC B NH, UK have published the research: An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis, in the Journal: (JOURNAL) of 28/02/2013
- what: The PROUD study was designed to explore the real-world effectiveness of PrEP (tenofovir-emtricitabine) by randomising HIV-negative gay and other men who have sex with men (GMSM) to receive open-label PrEP immediately or after a deferral period of 12 months.
- how: Trial procedures during the study are described in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.